Interventions to decrease the morbidity and mortality associated with implantable cardioverter-defibrillator shocks.

Area of Science:

• Cardiology
• Medical Devices
• Electrophysiology

Background:

• Implantable cardioverter-defibrillators (ICDs) are standard for preventing sudden cardiac death.
• ICD therapies and associated arrhythmias negatively impact patient quality of life, morbidity, and mortality.
• Preventing unnecessary ICD therapies is a critical clinical goal.

Purpose of the Study:

• To review recent evidence on interventions aimed at preventing implantable cardioverter-defibrillator (ICD) therapies.
• To identify strategies that can reduce the frequency of ICD shocks and improve patient outcomes.

Main Methods:

• Review of current literature on pharmacologic therapies for arrhythmia management.
• Analysis of evolving device programming techniques to reduce inappropriate shocks.
• Evaluation of the role of cardiac resynchronization therapy (CRT) in managing arrhythmias.
• Assessment of interventional procedures like catheter ablation and autonomic nervous system modulation.

Main Results:

• Pharmacologic therapy remains a cornerstone, though new drug evidence is limited.
• Evolving programming techniques effectively decrease inappropriate ICD shocks.
• Cardiac resynchronization therapy (CRT) improves quality of life and survival, partly by reducing arrhythmia burden.
• Catheter ablation and autonomic nervous system modulation show promise in minimizing ICD therapy.

Conclusions:

• Pharmacologic therapy and device programming are essential for ICD patient care.
• The benefits and role of CRT in managing ventricular arrhythmias are increasingly recognized.
• Advancements in catheter ablation and understanding of the autonomic nervous system offer new avenues to reduce ICD shocks.